# Department Of Defense - Air Force – FDA Inspection, Mar 7, 2019

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-air-force/a3ce80c1-53ea-4725-b763-ba59bde65892
Source feed: FDA_Inspections

> FDA inspection 1081722 of Department Of Defense - Air Force, March 07, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081722
- Company Name: Department Of Defense - Air Force
- Inspection Date: 2019-03-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1246901 - 2024-08-14
- FDA Inspection 1019124 - 2017-07-10
- FDA Inspection 921583 - 2015-04-02
- FDA Inspection 829267 - 2013-04-25
- FDA Inspection 734698 - 2011-07-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/department-of-defense-air-force/4cfce312-fad3-4dbc-9071-c358c5912770

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
